Our three products hold a true medical added-value with huge economic & societal impacts and a 5-year technical lead.
EXPERT SERVICES
O.V.E.R©
Services based on our patented analysis method and our SaaS operated in-house, we propose:
- Assessment of Drug Sequestration by Medical Devices
- Support of R&D and Medical Department of Health Industry
- Ability to propose new treatment plans & risk management strategies
SaaS
EUCLID©
The First Predictive Intelligence Platform for Molecule-Membrane Interactions
- NeckEpur has developed a digital twin, called EUCLID©, that provides a better understanding of molecule-membrane interactions, including drug sequestration phenomena by medical devices, transforming the initial in vitro method into a true in silico approach, paving the way for on-the-spot useat the patient’s bedside.
- In the future, our in-house AI-based technology will enable continuous, controlled, reliable, andaccelerated learning that can be extended to other fields such as membrane design, molecular design, and clinical use at the patient’s bedside.
The future of blood filtration: AI-powered blood filtration intelligence
- First patented active & selective blood filters (system + process)
- Functionalized membranes enabling targeted capture of molecules
- AI-assisted development through instantiation
- Scientific concept validated
- First model developed
- 17 international scientific publications supportive of the PoC